CCL2 and breast carcinoma: Monocyte chemoattractant protein‐1 (MCP‐1) is a chemotactic protein that has been widely implicated in breast cancer progression and metastasis as a pro‐progression and pro‐metastatic chemokine, and is a promising target for anti‐metastatic therapies.6